{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:57:02Z","timestamp":1794560222917,"version":"4.9.1"},"reference-count":11,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Ophthalmology"],"published-print":{"date-parts":[[2023,1]]},"abstract":"\n Purpose<\/jats:title>\n To report the effect of subtenon triamcinolone acetonide (TA) injection in the treatment of serous choroidal detachment (SCD) after glaucoma surgery.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n In this prospective case series, patients with persistent, non-resolving, or progressive SCD after glaucoma surgery were enrolled. For those with non-resolving or progressive SCD despite of using systemic corticosteroids, topical atropine and topical steroids, one milliliter of TA (40mg\/mL) was injected inferotemporally into the posterior subtenon space.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Sixteen consecutive patients with a mean\u2009\u00b1\u2009SD age of 70.12\u2009\u00b1\u200911.12 years were included in this study. After injection of subtenon TA, SCD was completely resolved after 1 to 4 weeks, with deepening of the anterior chamber in all cases. All cases were followed for at least 6 months after the injection with no signs of recurrence.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Subtenon injection of TA is a safe and effective modality of treatment for resolving a persistent or progressive SCD after glaucoma surgeries.<\/jats:p>\n <\/jats:sec>","DOI":"10.1177\/11206721221108253","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T02:04:58Z","timestamp":1655172298000},"page":"319-323","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Subtenon triamcinolone injection to treat serous choroidal detachment after glaucoma surgery: A case series"],"prefix":"10.1177","volume":"33","author":[{"given":"Naveed","family":"Nilforushan","sequence":"first","affiliation":[{"name":"Eye Research Center, The Five Senses Institute, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9490-1675","authenticated-orcid":false,"given":"Navid","family":"Abolfathzadeh","sequence":"additional","affiliation":[{"name":"Eye Research Center, The Five Senses Institute, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Najafzadeh","sequence":"additional","affiliation":[{"name":"Eye Research Center, The Five Senses Institute, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Samimifar","sequence":"additional","affiliation":[{"name":"Eye Research Center, The Five Senses Institute, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"bibr1-11206721221108253","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000131"},{"key":"bibr2-11206721221108253","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2019.10.035"},{"key":"bibr3-11206721221108253","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e31816f7647"},{"key":"bibr4-11206721221108253","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37220-3"},{"key":"bibr5-11206721221108253","doi-asserted-by":"publisher","DOI":"10.17925\/USOR.2020.13.2.76"},{"key":"bibr6-11206721221108253","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012464"},{"key":"bibr7-11206721221108253","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-15-13"},{"key":"bibr8-11206721221108253","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051556"},{"key":"bibr9-11206721221108253","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3182923463"},{"key":"bibr10-11206721221108253","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e31820d7e4e"},{"key":"bibr11-11206721221108253","unstructured":"Triamcinolone Injections for Persistent Choroidal Effusions Post Glaucoma Surgery (TRICEPS). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02917564 (accessed 22 April 2022)."}],"container-title":["European Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11206721221108253","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/11206721221108253","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11206721221108253","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:44:05Z","timestamp":1777405445000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/11206721221108253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1177\/11206721221108253"],"URL":"https:\/\/doi.org\/10.1177\/11206721221108253","relation":{},"ISSN":["1120-6721","1724-6016"],"issn-type":[{"value":"1120-6721","type":"print"},{"value":"1724-6016","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]}}}